News

Making use of the ‘new normal’ of wearable technology in clinical practice

Rapid development of personal technologies may lead to improved outcomes but additional challenges for the clinical and research communities dealing with conditions like inflammatory arthritis, according to a presenter at the 2020 Interdisciplinary Autoimmune Summit.Alexis Ogdie, MD, MSCE, associate professor of medicine and epidemiology at the Perelman School of Medicine at the University of Pennsylvania,…

News

Discovery of cell surface protein may lead to CAR-T for inflammatory diseases

Cellular senescence has both positive and negative effects in the body.The process can lead to tumor suppression and plays a key role in wound healing. However, it also can cause inflammation that results in long-term tissue damage and contributes to chronic diseases, such as liver fibrosis, lung cancer and osteoarthritis.A study published in Nature detailed…

News

GIs, patients highly satisfied with telehealth during COVID-19

Both patients and gastroenterologists have been highly satisfied with telehealth services during the COVID-19 pandemic, according results from a survey published in Clinical Gastroenterology and Hepatology.Naresh T. Gunaratnam, MD, of Huron Gastroenterology Associates in Michigan, and colleagues wrote that policy changes that made telehealth more accessible have helped fulfill two critical aims of health care…

News

Entyvio linked with lower risk for non-infectious adverse events in Crohn’s

Entyvio yielded a lower risk for non-infectious serious adverse events than TNF antagonist therapy in Crohn’s disease, according to a study published in Alimentary Pharmacology and Therapeutics.However, the same was not true regarding serious infections. Further, there was no significant difference in achievement of disease remission between Entyvio (vedolizumab, Takeda) and TNF antagonist therapy.“Post-hoc secondary…

News

Clinicians managing IMIDs offer insights into pandemic as new COVID-19 cases mount

Clinicians who manage patients with immune-mediated diseases can offer useful insight into the management of COVID-19, according to presenters at a roundtable discussion at the 2020 Interdisciplinary Autoimmune Summit.“It is clear that the U.S. has become an outlier, continuing to break records of new case counts every day,” Cassandra Calabrese, DO, of the Cleveland Clinic,…